Several cardiac diseases, like supra-ventricular arrhythmias, myocardial infarction, left ventricular remodelling with aneurysms and heart valve diseases like mitral valve stenosis, infective endocarditis and prosthetic heart valves predispose to intracavitary thrombus generation, which is the main source for peripheral embolism. Often the main unifying risk factor for cardio-embolism is atrial fibrillation (AF) and many of these cardio-embolic complications are transient ischemic cerebrovascular attacks or strokes with various levels of residual compromise. Cardiac imaging with different techniques and modalities has the potential to effectively stratify thrombo-embolic risk in patients with AF and other cardiac comorbidities. In this review we tried to characterize the current clinical role of different cardiac imaging methods, specifically echocardiography, cardiac computed tomography and cardiovascular magnetic resonance, in identifying cardio-embolic risk factors and guiding antithrombotic therapy, with a particular attention to novel patents and future developments of these techniques.
Keywords: Atrial fibrillation, cardio-embolic, computed tomography, echocardiography, magnetic resonance imaging, thrombus, transesophageal.
miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery
MicroRNA Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging (Discontinued) Adipocytes and Abdominal Aortic Aneurysm: Putative Potential Role of Adipocytes in the Process of AAA Development
Current Drug Targets Cellular Mechanisms of Brain Injury and Cell Death
Current Pharmaceutical Design Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm
Current Pharmaceutical Design Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture
Current Pharmaceutical Design IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology Statins: A Valuable Tool for the Prevention/Regression of Abdominal Aortic Aneurysms
Vascular Disease Prevention Blood Pressure and White Matter Lesions in Patients with Vascular Disease: The SMART-MR Study
Current Neurovascular Research The Cardiologist in the Periphery: Indications and Usefulness of Peripheral Artery Invasive Angiography in Patients Undergoing Coronary Angiography
Current Medical Imaging Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design Neuroinflammation is Associated with Brain Extracellular TAU-Protein Release After Spontaneous Subarachnoid Hemorrhage
Current Drug Targets Different Factors Influence Recanalisation Rate After Coiling in Ruptured and Unruptured Intracranial Aneurysms
CNS & Neurological Disorders - Drug Targets Preoperative and Follow up Multi-Detector Row CT Angiography (MDCTA) in the Evaluation of Interrupted Aortic Arch (IAA)
Current Medical Imaging Analysis of Nitric Oxide (NO) in Cerebral Vasospasm After Aneursymal Bleeding
Reviews on Recent Clinical Trials Lipids and Non-Cardiac Vascular Disease: A Lecture Overview
Current Vascular Pharmacology